Colon cancer survival rates improved with daily low-dose aspirin
Colon cancer survival rates are improved with daily low-dose aspirin. The Norwegian study found that among 23,000 colon cancer patients, those taking a low-dose aspirin daily were 15 percent less likely to die over the course of several years. The findings do not suggest that aspirin can extend the lives of colon cancer survivors, but ...click here to read more